Qingdao Haier Biomedical Co (SHSE:688139) Total Liabilities : ¥1,130 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Total Liabilities?

Qingdao Haier Biomedical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,130 Mil.

Qingdao Haier Biomedical Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,075.02 Mil) to Dec. 2023 (¥1,085.72 Mil) and increased from Dec. 2023 (¥1,085.72 Mil) to Mar. 2024 (¥1,130.34 Mil).

Qingdao Haier Biomedical Co's annual Total Liabilities increased from Dec. 2021 (¥1,261.08 Mil) to Dec. 2022 (¥1,340.65 Mil) but then declined from Dec. 2022 (¥1,340.65 Mil) to Dec. 2023 (¥1,085.72 Mil).

Qingdao Haier Biomedical Co Total Liabilities Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Total Liabilities Chart

Qingdao Haier Biomedical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

581.08

1,165.45

1,261.08

1,340.65

1,085.72

Qingdao Haier Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,240.77	1,153.55	1,075.02	1,085.72	1,130.34

Qingdao Haier Biomedical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Qingdao Haier Biomedical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	941.663	+	(8.689	+	135.368
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,086

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	5525.683	-	4439.963
	=	1,086

Qingdao Haier Biomedical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	987.89	+	(8.732	+	133.716
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,130

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	5686.836	-	4556.497
	=	1,130

Qingdao Haier Biomedical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Haier Road, Branding Building, Qingdao, CHN, 266101

Website

http://www.haiermedical.com

Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.

Executives

Zhang Jiang Tao	Core technical personnel
Liu Ji Yuan	Core technical personnel
Teng Pei Kun	Core technical personnel
Wang Guang Sheng	senior management
Gong Yi	Director
Huang Yan Li	senior management
Chen Hai Tao	Senior management, core technical personnel
Liu Zhan Jie	Directors, senior managers, core technical personn
Mo Rui Juan	senior management
Wang Wen Fu	Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines